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Abstract  
 Milk and derived products contain essential nutrients, such as proteins, lactose, 
minerals, vitamins, and enzymes. Additionally, despite of their low concentrations in 
milk, many other minor constituents present important physiological and/or 
technological roles (e.g. hormones, growth factors). Dairy industries face many 
challenges regarding milk processing. Also, the full knowledge on these constituents’ 
physiological roles and effects on health is still lacking. Technological advances, 
innovative research approaches using metabolic engineering, systems and synthetic 
biology, and novel production methods will allow the production of higher amounts of 
such constituents, to produce them in such a way that recovery is easier and to 
produce differentiated compounds, thus revolutionizing the fields of personalized 
nutrition and functional foods. This chapter focuses on the description of the minor milk 
constituents, their applications and main technological challenges. Future perspectives 
and concerns related to these constituents are discussed. 
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1. Introduction  
 Milk and derived products contain several essential nutrients and protective 
agents, such as enzymes and growth factors (Fox and Kelly, 2006a). However, lately a 
decrease in milk consumption in the Western societies has been observed, mainly due 
to negative effects on health that have been claimed regarding its intake (Haugh et al., 
2007). The high content of saturated fatty acids in milk has been pointed out  as being 
responsible for negative effects contributing to heart diseases, weight gain and obesity 
(Insel et al., 2004). Nevertheless, this issue is controversial since there are many milk 
components that promote health benefits including oleic acid, conjugated linoleic acid, 
omega-3 fatty acids, proteins, vitamins, minerals and bioactive compounds, and 
various milk proteins and their peptides have been suggested to possess anti-cancer 
activity (Duarte et al., 2011; Rodrigues et al, 2009; Rodrigues and Teixeira, 2009). 
Regarding the milk fat, an increase of the mean gastric emptying time has been 
observed when comparing the consumption of whole with half-skimmed milk, thus 
whole milk promotes an increase of the gastrointestinal transit time. Therefore, the 
consumption of whole milk may be valuable for regulating appetite and it has not been 
proven that moderate consumption of milk fat is related to an increase of developing 
certain diseases. The relationship between milk or milk products consumption and 
possible negative health effects is still not fully explored. For example, the interaction 
between carbohydrates and protein in milk exposed to heat may result in products 
whose effects have not been accurately assessed. The association between food and 
health is well established (Kussmann and Fay, 2008) and some studies have shown 
that variable risk factors seem to be of greater significance for health than previously 
anticipated (Yusuf et al., 2004). Prevention of disease may in the future be just as 
important as treatment of diseases (Torres et al., 2010). Indeed, currently many 
consumers are extremely conscious of health-properties of food, and the market for 
healthy food and food with special health benefits is increasing (Haugh et al., 2007).  
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 Milk is a complex matrix made up of components, which per se may have 
negative or positive health effects, respectively. The concentration in milk of several 
nutrients, including the minor constituents, can be manipulated through feeding 
regimes and it can be increased or diminished towards a healthier product. The 
development of functional and healthy foods has become one of the most exciting 
fields of research in recent years (Pouliot and Gauthier, 2006; Michaelidou, 2008; 
Michaelidou and Steijns, 2006; Kaput, 2008). The relative ease with which milk can be 
converted into a wide variety of products makes it an extremely useful base material. In 
some cases, milk undergoes relatively limited processing, consisting of heat treatment 
to increase the product microbial shelf life and homogenization to increase the physical 
shelf life through retarding fat separation (Huppertz and Kelly, 2009). Other well known 
processes involve the acid-induced coagulation of milk to produce yoghurt, or the 
enzymatic coagulation of milk to manufacture cheese. In addition, milk may be spray-
dried or used as a base from which constituents, e.g. proteins, fats or minor 
constituents are isolated. As a result of the widespread applications and use of milk 
and milk products in human nutrition they have been the subject of intensive research 
in the last century.   
 This chapter focuses on the description of the minor constituents, enzymes, 
hormones, growth factors and organic acids in milk, as well as their applications and 
technological challenges. Finally, future perspectives and concerns related to these 
constituents will be discussed. 
 
2. Milk minor constituents 
 Milk is often described as a colloidal suspension, containing emulsified globules 
of fat, a heterogeneous family of major and minor proteins, the carbohydrate lactose, 
minerals, vitamins, enzymes (Huppertz and Kelly, 2009) and many other minor 
components that hold important physiological and/or technological roles such as 
immunoglobulins, hormones, growth factors, cytokines, nucleotides, peptides, 
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polyamines, enzymes and other bioactive peptides (Haug et al., 2007). The lipids in 
milk are emulsified in globules coated with membranes. The proteins are in colloidal 
dispersions as micelles. The casein micelles occur as colloidal complexes of protein 
and salts, primarily calcium (Keenan and Patton, 1995). Lactose and most minerals are 
in solution. Milk composition has a dynamic nature that varies with several factors 
(Ontsouka et al., 2003; Huppertz and Kelly, 2009):  
  (a) genetics (e.g. species, breed and individual);  
  (b) stage of lactation;  
  (c) health status of the individual animal; and  
  (d) environmental factors (e.g. feed, climate or method of milking).  
 
 Specific milk proteins are involved in the early development of immune 
response, whereas others take part in the non-immunological defense (e.g. lactoferrin) 
(Rodrigues et al., 2009). In addition to the major constituents, milk also contains a 
number of organic and inorganic compounds in small or trace amounts (e.g. peptides, 
amino acids, antioxidants, salts, nucleotides and vitamins), some of which affect both 
the processing and nutritional properties of milk. Table 1 summarizes the amounts of 
some of the most important minor milk constituents in milk from several species. 
  
2.1. Salts and Minerals 
 Milk salts are essentially phosphates, citrates, chlorides, sulphates, carbonates 
and biocarbonates of sodium, potassium, calcium and magnesium. Since milk contains 
organic and inorganic salts, the level of salts is by no means equivalent to the ash 
content (Huppertz and Kelly, 2009). The milk salt composition is also influenced by a 
number of factors, including species, breed, stage of lactation, health status, climate, 
and feed.  
 Although salts comprise less than 1% of the milk they influence its rate of 
coagulation and other functional properties. Calcium, magnesium, phosphorous and 
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citrate are distributed between the soluble and colloidal phases. Their equilibrium is 
altered by heating, cooling and by a change in pH. The solubility of calcium phosphate 
is strongly temperature-dependent and, unlike for most other compounds, decreases 
with increasing temperature (Pouliot et al., 1989). In their studies, these authors found 
that the levels of calcium and phosphate in the milk serum decrease progressively with 
temperatures increasing in the range of 4o - 90ºC. Heat-induced decreases in levels of 
serum magnesium and citrate were also observed but to a smaller extent. Levels of 
sodium and potassium in milk serum were not affected by heat treatment. Severe heat 
treatments (above 90ºC) may result in irreversible changes in the mineral balance in 
milk (Holt, 1995).  
 In addition to the major salts, milk also contains trace elements. Some elements 
come into the milk from feeds, but milking utensils and equipment are important 
sources of such elements as copper, iron, nickel and zinc. Mineral and vitamin contents 
of goat and sheep milk are mostly higher than in cow milk (Park et al., 2007). 
 
2.2. Vitamins  
 The fat-soluble vitamins A, D, E and K of milk are associated with the milk fat 
fraction, while the water-soluble vitamins B complex and C are associated with the 
water phase. Vitamins are unstable and processing can therefore reduce the effective 
vitamin content in milk. During processing, the fat-soluble vitamins are retained by the 
cream, while the water-soluble vitamins remain in skim milk or whey (Michaelidou and 
Steijns, 2006). 
 Several researchers suggested that slight deficiencies in B vitamins may 
constitute risk factors for vascular and neurological diseases and cancers (Brachet et 
al., 2004). A combined deficiency of folates and vitamin B12 has been associated with 
the development of dementia and Alzheimer’s disease among the eldery (Seshadri et 
al., 2002). Furthermore, folate, B6 and B12 influence the homocysteine metabolism. As 
elevated levels of plasma homocysteine constitute a risk factor for developing 
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cardiovascular disease, an increase in folate intake would be beneficial (Graham and 
O’Allaghan, 2000). Apart from the prevention of cardiovascular diseases, folates 
possess a protective role against child birth defects (Forssen et al., 2000; Molloy, 
2002). Also, there is growing evidence that a low folate status is linked to an increased 
cancer risk, particularly colon cancer (Rampersaud et al., 2002). Based on the 
evidence that B vitamins are beneficial for human health, they have been included in 
the list of nutraceuticals (Hugenholtz et al., 2002).  
 At an industrial scale, lactic acid bacteria (LAB) are used to increase the 
production levels of B vitamins in dairy products. Recent developments in LAB 
metabolic engineering include the re-routing of complex, biosynthetic pathways leading 
to the production of metabolites with a health benefit for the consumer, as is the case 
of the B vitamins. These advances could lead to novel functional foods with great 
potential for the application of LAB (Kleerebezem and Hugenholtz, 2003). Novel dairy 
foods, enriched through fermentation using multivitamin-producing organisms  with 
mutations in methylene tetrahydrofolate reductase, could compensate the B vitamin-
deficiencies known worldwide and could specifically be used in dietary foods for 
specific consumer groups (Sybesma et al., 2004). Using fermentation processes for the 
natural enrichment of foods presents key advantages over the enrichment of food 
through the addition of chemically synthesized vitamins. It enables the use of naturally 
occurring molecules in physiological doses and in an environment most suited for 
optimum biological activity (Michaelidou and Steijns, 2006). This is of extreme 
importance for dairy products, since some bioactive molecules do not work alone 
requiring their specific binding proteins or other milk proteins for biological activity. 
Additionally, it is important to notice that the use of these fortified fermented foods 
generally is not limited by legislation. However, as in all cases of food fortification, a 





2.3. Immune components  
 Milk plays an important role in mammalian host defense (Stelwagen et al., 
2009). Present in colostrums and milk of all lactating species, immunoglobulins (Ig) 
provide immunological protection of the offspring against microbial pathogens and 
toxins. Depending on the species one can find different types of immunoglobulins and 
concentrations. In colostrum, the concentration of immunoglobulins is particularly high, 
with IgG being the major immunoglobulin class present in ruminant milk, in contrast to 
IgA being the major immunoglobulin present in human milk. Immunoglobulins are 
transported into mammary secretions via specialized receptors. In addition to 
immunoglobulins, both colostrum and milk contain viable cells, including neutrophils 
and macrophages, which secrete a range of immune-related components into milk. 
These include cytokines and antimicrobial proteins and peptides, such as lactoferrin, 
defensins and cathelicidins. Mammary epithelial cells themselves also contribute to the 
host defense by secreting a range of innate immune effector molecules. A detailed 
understanding of these proteins and peptides offers great potential to add value to the 
dairy industry. This is demonstrated by the widespread commercial applications of 
lactoferrin isolated from bovine milk (Rodrigues et al., 2009). Furthermore, some 
immunoglobulins may influence milk processing, as is the case of IgM that plays an 
important role in the creaming of cow’s milk (Huppertz and Kelly, 2009). Sheep and 
goat milk are also important sources of minor milk proteins with immune effects 
including immunoglobulins, lactoferrin, transferrin, ferritin, proteose peptone, 
calmodulin (calcium binding protein), prolactin, and folate-binding protein. Non-protein 
nitrogen (NPN) contents of goat and human milks are higher than in cow milk (Park et 
al., 2007).  
 
2.4. Bioactive peptides 
 Due to the advances in biological research tools, milk and whey proteins have 
been recognized to contribute to human health through latent biological activity 
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(Rodrigues and Teixeira, 2009). These proteins are hydrolyzed by certain proteolytic 
enzymes releasing the so-called bioactive peptides that are capable of modulating 
specific physiological functions (Michaelidou, 2008). 
 Bioactive peptides can be obtained from precursor proteins through enzymatic 
hydrolysis by digestive enzymes derived from microorganisms or plants, or through 
fermentation of milk with proteolytic starter cultures (Korhonen and Pihlanto-Leppala, 
2006). These peptides have been shown to exert various activities affecting the 
digestive, cardiovascular, immune and nervous system. Specifically, antihypertensive, 
antioxidative, antithrombotic and hypocholesterolemic peptides can affect the 
cardiovascular system. Opioid peptides, with agonist or antagonist activity, may 
regulate the nervous system. Mineral-binding, anti-appetizing and antimicrobial 
peptides exert their action on the gastrointestinal system. Immunomodulatory and 
cytomodulatory peptides are of special interest for the immune system. The occurrence 
and biological activity of these peptides in milk and its derivatives has been extensively 
reviewed (Clare and Swaisgood, 2000; FitzGerald and Meisel, 2000; Meisel and 
FitzGerald, 2000; Korhonen and Pihlanto-Leppala, 2006; Kilara and Panyam, 2003; 
FitzGerald et al., 2004; Lopez-Fandino et al., 2006). 
 Among the bioactive peptides from milk, those with blood pressure lowering 
effects are receiving special attention (FitzGerald et al., 2004). Some antihypertensive 
products based on milk peptides with clinically proven health benefits are currently 
available in the market (Lopez-Fandino et al., 2006). Sheep and goat milk proteins are 
important sources of bioactive ACE-inhibitory peptides and antihypertensive peptides 
(Park et al., 2007). Goat milk is being regarded as an appealing research area, as it 
has been less explored than bovine milk, but also because novel peptidic angiotensin-
converting enzyme (ACE) inhibitors have been found in goat milk hydrolysates 
(Geerlings et al., 2006). As sheep milk is usually converted to cheese, and mostly to 
traditional cheeses, ovine cheese varieties can be regarded as a valuable source for 
ACE-inhibitory peptides. The presence of hypotensive peptides, naturally formed in 
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cheese, has been found to depend on a balance between their formation and their 
degradation (Ryhanen et al., 2001). Further research has to be conducted to evaluate 
the long-term physiological effects of consuming such peptides.  
 Another group of milk bioactive peptides that has aroused the interest of the 
scientific community are the caseinophosphopeptides (CPPs), since they have been 
suggested to enhance vitamin D-independent bone calcification in rachitic infants 
(Mellander, 1950). Its mechanism of action seems to be related to the presence, in 
their amino acid sequence, of a cluster of three phosphoserine residues followed by 
two glutamic acid residues. This sequence produces, at the intestinal pH, a negative 
core responsible for mineral binding (Ca, Zn, Mg) and for resistance of these peptides 
to proteolytic gastrointestinal enzymes. These two structural features support the 
hypothesis that CPPs could increase Ca passive diffusion and utilization in vivo by 
increasing Ca solubility at physiological pH of the distal small intestine. However, 
results from in vivo studies are still controversial, as there are many factors that could 
affect Ca availability, such as the various dietary compounds present at the same time 
in the intestinal lumen (FitzGerald, 1998; Vegarud et al., 2000; Erba et al., 2001).  
 Components that are able to transmit biochemical messages have attracted 
particular scientific attention as potential bioactive ingredients in a range of biomedical 
and functional foods, since they have been shown to be potent growth stimulants and 
mediators for a range of mammalian cells, both in vitro and in vivo (Smithers, 2004). 
Among them, non-peptide trophic factors play an important role in maintaining 
gastrointestinal mucosal mass and modulating the immune system via multiple 




 The interest in naturally occurring polyamines in milk, such as putrescine, 
spermidine and spermine, has been increasing in the last decades (Michaelidou, 
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2008). Polyamines consist of flexible polycations that are fully charged under 
physiological pH conditions. They fulfill a number of roles in cellular metabolism and 
are essential for cell growth and proliferation (Löser, 2000; Eliassen et al., 2002; 
Gugliucci, 2004; Larqué et al., 2007). Besides being involved in DNA, RNA and protein 
synthesis, the most important function of polyamines is the mediation of the action of all 
known hormone and growth factors.  
 The polyamine requirements that cannot be met by biosynthesis have to be 
satisfied by exogenous polyamines consumed from the food (Jeevanandam et al., 
1997). It has been suggested that gut maturation is sustained by dietary polyamines; 
therefore its supplementation in formula-fed infants may prove beneficial. Dietary 
polyamines may therefore decrease cow’s milk allergen absorption and reduce the risk 
of food allergy (Dorhout and Muskiet, 1999). 
 Furthermore, polyamines may be important for the fidelity of the enhanced DNA 
transcription and RNA translation, that occurs in response to infection and during tissue 
repair, gut growth after surgery, and in gut barrier functions (Grimble and Grimble, 
1998). Additionally, dietary polyamines might become important with ageing as cell 
proliferation slows with age (Nishimura et al., 2006). On the contrary, there are 
situations where diets low in polyamines may be beneficial such as in the treatment of 
some tumors (Gugliucci, 2004; Larqué et al., 2007). Accordingly, the effect of 
polyamines on human health may vary among people.  
 
2.6. Nucleotides 
 Nucleotides, nucleosides and nucleobases belong to the non-protein-nitrogen 
(NPN) fraction of milk and are known to have a specific physiological impact in early life 
(Michaelidou, 2008). Nucleosides and nucleobases, the preferred forms for absorption 
in the intestine, are suggested to be the acting components of dietary and/or 
supplemented nucleic acid-related compounds in the gut. Schlimme et al. (2000) 
reviewed the composition and biological activity of these minor constituents in bovine 
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milk and colostrum. Due to the properties and roles of dietary nucleotides, an increased 
interest in their use for infant nutrition has been registered, and supplementation with 
ribonucleotide salts in the manufacture of infant and follow-on formulae has been 
allowed by the European Commission (Gil and Rueda, 2002; Yu, 2002; Aggett et al., 
2003; Alles et al., 2004). 
 Recently it has been found that modified nucleosides may inhibit cell 
proliferation and activate apoptosis. Food-derived inducers of apoptosis may be of 
significance as exogenous anti-carcinogens in the control of malignant cell proliferation, 
where the intestinal tract could be the primary target site for a possible selective 
apoptotic stimulant against malignant cells (Schlimme et al., 2000). 
 Furthermore, dietary nucleotides influence biosynthetic processes and modulate 
gene expression (Sanchez-Pozo and Gil, 2002). Functions of the system and the brain 
also appear to benefit from food supplementation with nucleosides and nucleotides 
(Yamamoto et al., 1997), although its effects in the gut seem to depend on the type of 
damage.  
 
2.7. Proteose-peptones  
 The potential exploitation of selected milk proteins as ingredients in functional 
food products has been the reason for an increasing interest in their fractionation 
(Rodrigues and Teixeira, 2009; Zuniga et al., 2009). Heating of skimmed milk (95°C, 30 
min) followed by acidification promotes the denaturation of whey proteins and their co-
precipitation with caseins, which are insoluble at pH 4.6 (Girardet and Linden 1996). In 
spite of these drastic conditions, a heterogeneous fraction called proteose peptone 
(PP) remains soluble (Huppertz and Kelly, 2009). The PP fraction of milk appears to 
consist of two groups of proteins/peptides, i.e. those that are indigenous in milk (e.g. 
osteopontin, proteose peptone 3 (PP3)), and those that result from the action of 
proteolytic enzymes (primarily plasmin, on caseins). The principal components of the 
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PP fraction have been designated as components 3, 5, and 8 (PP3, PP5, PP8) 
(Innocente et al., 1999).  
 The primary structure of PP3 includes a polypeptide backbone of 135 amino 
acid residues containing five phosphorylated serines, two threonine-linked O-
glycosylations, and one N-glycosylation, with an apparent molecular mass of 28 kDa 
(Sorensen et al. 1997). Also, a glycoprotein with apparent molecular mass of 18 kDa is 
associated with component PP3, corresponding to the 54-135 fragment released by 
plasmin hydrolysis in milk (Sousa et al., 2007).The PP3 is extremely hydrophobic and 
particularly interesting because of its functional properties, such as its emulsifying 
power, strong affinity for oil–water interface, strong foaming properties, and 
biochemical role (Rodrigues et al., 2003). Although not many studies have been 
conducted on the biological functions of PP3, some researchers demonstrated its 
immunostimulation (Sugahara et al., 2005) and prebiotic effects (Etienne et al., 1994), 
as well as its role in caries prevention (Aimutis, 2004; Grenby et al., 2001). 
 
2.8. Branched chain amino acids and other amino acids  
 Milk is rich in essential amino acids and branched chain amino acids (Haug et 
al., 2007). These amino acids have unique roles in human metabolism; in addition to 
provide substrates for protein synthesis, suppress protein catabolism and serve as 
substrates for gluconeogenesis; they also trigger muscle protein synthesis and promote 
protein synthesis (Wolfe, 2002; Layman, 2003; Etzel, 2004).  
 Branched chain amino acid leucine in particular triggers muscle protein 
synthesis which is sensed by the insulin signaling pathway (Etzel, 2004). The 
stimulated insulin secretion caused by milk, is suggested to be caused by milk proteins, 
and as shown by Nilsson et al. (2007) a mixture of leucine, isoleucine, valine, lysine 
and threonine resulted in glycemic and insulinemic response resembling the response 
seen after ingestion of whey. A combination of milk with a meal with high glycaemic 
load (rapidly digested and absorbed carbohydrates) may stimulate insulin release and 
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reduce the postprandial blood glucose concentration (Frid et al., 2005). A reduction in 
postprandial blood glucose is favorable, and it is epidemiological evidence suggesting 
that milk may lower the risk of diseases related to insulin resistance syndrome (Pereira 
et al., 2002). 
 
2.9. Taurine  
 Taurine is an essential amino acid for preterm neonates and for specific 
consumer groups that are at risk for taurine deficiency, such as patients requiring long-
term parenteral nutrition (including premature and newborn infants); diabetes patients, 
those with chronic hepatic, heart or renal failure (Lourenco and Camilo, 2002; Li et al., 
2005). It is suggested that during parenteral nutrition, supplementation of 50 mg taurine 
per kg body weight may be required. Park and collaborators (2007) reported that 
normal cow milk contains 0.6 mg of taurine per 100 ml (1 mol/100 ml), while cow 
colostrum has 8 mg/100 ml. Human mature milk contains significantly more taurine (30 
mol /100 ml) than cow milk or milk from other species, such as sheep (14 mol/100 
ml), but similar to goat (56 mol/100 ml) (Park et al., 2007; Belewu and Adewole, 
2009). Taurine contents of milk can be increased through feeding although there are 
some issues with its degradation as was suggested by Kim and Park (2003) in their 
patent (US Patent 6645519).   
 Taurine is the most abundant intracellular amino acid in humans. It may be 
synthesized in the body from methionine and cysteine, but in healthy individuals milk in 
the diet is the usual source of taurine. It is implicated in numerous biological and 
physiological functions, such as bile acid conjugation and cholestasis prevention, 
antiarrhythmic / inotropic / chronotropic effects, central nervous system modulation, 
retinal development and function, endocrine/metabolic effects and antioxidant/anti-
inflammatory properties (Lourenco and Camilo, 2002). This essential amino acid has 
been shown to have endothelial protective effects (Fennessy et al., 2003), it may 
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function principally as a negative feedback regulator, helping to dampen immunological 
reactions before they cause too much damage to host tissues or to the leukocytes 
themselves (Park et al., 2002), and it has been shown to be analgesic (Li et al., 2005; 
Silva et al., 1993). 
 
2.10. Glutathione  
 Milk is a good source of glutathione that acts in the organism as an antioxidant. 
Glutathione is a tripeptide of the sulphur amino acid cysteine, plus glycine and glutamic 
acid. It can be oxidized forming oxidized glutathione, and in this reaction it may remove 
reactive oxygen species (ROS), thereby regulating the level of ROS in the cells. 
Glutathione participates in the regulation of insulin production in pancreatic cells, as 
ROS inhibit expression of the pro-insulin gene. Glutathione appears to have different 
important roles in leukocytes, as a growth factor, as an anti-apoptotic factor in 
leukocytes and to regulate the pattern of cytokine secretion (Sprietsma, 1999). 
Moreover, glutathione is central for antioxidative defense in the lungs, which may be 
very important in connection with lower respiratory infections including influenza (Cai et 
al., 2003).  
 
3. Milk enzymes  
 Indigenous enzymes are milk constituents that originate from four main sources, 
blood plasma, secretory cell cytoplasm, milk fat globule membrane (MFGM), and 
somatic cells (leucocytes) (Fox and Kelly, 2006a). Around 70 indigenous enzymes 
were identified in normal bovine milk (Fox, 2003). Table 2 summarizes the 
concentrations and activities of some indigenous enzymes present in the milk of 
several species. Moreover, Table 3 presents examples of some of these enzymes that 
have been well characterized regarding their activity and significance. Additionally, in 
Table 4 some indigenous enzymes that have been suggested to play a key role in the 
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manufacture and/or quality of milk and its derivatives are presented. The best 
characterized enzymes in milk include N-acetyl--D-glucosaminidase (NAGase); acid 
phosphatase (AcP); alkaline phosphatase (AIP); amylase; catalase; -glutamyl 
transferase (-GGT); glutathione peroxidase (GSH); lactoperoxidase (LPO); lipoprotein 
lipase (LPL); lysozyme; plasmin; ribonuclease (RNase); sulphydryl oxidase (SHOx); 
superoxide dismutase (SOD); and xanthine oxidoreductase (XOR) (Kelly and Fox, 
2006). Most of the indigenous enzymes in milk have no obvious physiological role in 
biosynthesis and secretion of milk (Fox and Kelly, 2006a). Moreover, since these 
enzymes have no essential beneficial effect on the nutritional or organoleptic attributes 
of milk, their destruction by heat is one of the purposes of many dairy processes. 
Besides indigenous enzymes, milk also contains proteases and lipases that are 
produced by contaminating bacteria during handling and processing. Even when 
several heat treatment steps are used to prepare milk products, these will not be 
enough to inactivate all the enzymes and extreme heat treatments will have adverse 
effects on the products (Chen et al., 2003). Proteinases and lipases surviving 
pasteurization and spray-drying treatments can cause important changes in the 
functionality and flavor of milk products (Renner, 1988; Visser, 1981; Deeth, 2006).  
 
3.1. Lactoperoxidase 
 Lactoperoxidase (LPO; EC 1.11.1.7) belongs to the peroxides family of 
enzymes and is secreted from mammary, salivary and other mucosal glands, acting as 
a natural antibacterial agent. It has the ability to catalyze certain molecules, including 
the reduction of hydrogen peroxide (Bjorck, 1978). This enzyme catalyzes peroxidation 
of thiocyanate and some halides (such as iodine and bromium), which ultimately 
generates products that inhibit and/or kill a range of bacterial species (Kussendrager 
and van Hooijdonk, 2000; Pruitt, 2003).  
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 Several isozymes of LPO have been reported as a result of the differences in 
the level of glycosylation and deamination of glutamine (Gln) or asparagine (Asn) (Fox 
and Kelly, 2006a). LPO mass is 78.0 kDa and its primary structure contains 612 amino 
acids (Cals et al., 1991). The molecule is highly structured, with 65% -structure, 23% 
-helix and 12% unordered structure (Sievers, 1980). LPO binds Ca2+, which has a 
major effect on its stability, including its heat stability. At a pH below 5.0, the Ca2+ is 
lost, with a consequent loss of stability.  
 During the pasteurization process, LPO is not inactivated, suggesting its 
stability as a preservative (Table 3). This enzyme’s biological function has been mainly 
associated with its antimicrobial activity, and to date there is no report on other direct 
functions such as immunomodulation or cancer prevention (Rodrigues and Teixeira, 
2009). 
 
3.2. Catalase  
 Catalase (H2O2:H2O2 oxidoreductase; EC 1.11.1.6) catalyses the decomposition 
of hydrogen peroxide in water and oxygen, and also oxidizes reducing agents. The 
catalase activity in milk varies with feed and stage of lactation, and especially during 
mastitis its level is markedly increased (Johnson, 1974). It has been reported that this 
indigenous enzyme is concentrated in the cream (specific activity is 12 times higher 
than in skimmed milk), thus the MFGM (Milk Fat Globule Membrane) is usually used as 
the starting material for isolating catalase from milk (Kitchen et al., 1970).   
 Catalase has a molecular mass of 250 kDa (Ito and Akuzawa, 1983a) and three 
isozymes have been found in the catalase isolated from cream (Ito and Akuzawa, 
1983b). Furthermore, catalase is relatively heat labile (Farkye and Imafidon, 1995) and 
its inactivation has been evaluated as a possible index of thermization of milk (almost 
completely inactivated by heating at 65ºC for 16 s) by Hirvi and Griffiths (1998).  
 
3.3. Xanthine oxidoreductase 
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 Xanthine oxidoreductase (XOR; EC 1.13.22; 1.1.1.204) is a milk indigenous 
enzyme capable of oxidizing xanthine and hypoxanthine with the concomitant reduction 
of O2 to H2O2 (Fox and Kelly, 2006a). For its catalytic activity, XOR has been found to 
require FAD+ (Massey and Harris, 1997; Harrison, 2004). XOR is concentrated on the 
MFGM, in which it is the second most abundant protein representing 20% of the protein 
of the MFGM. This enzyme is a dimer with two identical subunits (146 kDa), each 
containing 1332 amino acid residues in the case of the bovine milk enzyme. Each XOR 
monomer contains one atom of molybdenum (Mo), one molecule of FAD+ and two 
Fe2S2 redox centres. NADH acts as a reducing agent. 
 Milk is a good source of XOR, at least part of which is transported to the 
mammary gland via the blood stream. Human milk contains XOR, although its levels 
vary markedly during lactation. The XOR activity in human milk is low because 95 to 
98% of the enzyme molecules lack Mo (Atmani et al., 2004). Also, the level of XOR 
activity in goat, sheep and buffaloes milk is low (Pandya and Khan, 2006). The level of 
XOR activity in milk can be increased by supplementing the diet with Mo (Fox and 
Kelly, 2006a). 
 
3.4. Proteinases  
 Proteinases correspond to the group of proteolytic enzymes that act internally 
on polypeptide chains, rather than cleaving off single amino acids or dipeptides from 
the ends of polypeptide chains (Chen et al., 2003). Furthermore, this group of 
proteinases is generally classified in four sub-groups on the basis of the mechanism of 
action of the enzyme:  
  (a) serine proteinases, such as plasmin;  
  (b) cysteine (or sulphydryl) proteinases, such as cathepsin B;  
  (c) aspartic (or acid) proteinases, such as cathepsin D; and  




Two particular indigenous milk proteinases have been studied in detail, namely plasmin 
and cathepsin D (Kelly and Fox, 2006). These indigenous proteinases arise from 
mammary tissue cells, blood plasma or leucocytes (Fox and Kelly, 2006a). 
 
3.4.1. Plasmin 
 The principal milk indigenous proteinase is plasmin (EC 3.4.21.7) (Table 3). The 
plasmin system has five elements: plasmin, plasmin inhibitors, the inactive zymogen 
plasminogen, plasminogen activators (PAs) and inhibitors of plasminogen activators 
(Grufferty and Fox, 1988). This system enters milk from blood and plasmin activity 
increases during a mastitic infection and in late lactation. Plasmin in milk occurs mainly 
as the inactive precursor plasminogen (Rollema et al., 1981). Plasminogen is activated 
through proteolysis by PAs, which are serine proteinases (Fang and Sandholm, 1995). 
In milk, plasminogen, plasmin and PAs are associated with the casein micelles and are 
concentrated in rennet-coagulated cheese curds and casein, while the inhibitors of PAs 
and plasmin are soluble in the milk serum (Fox and Kelly, 2006a). 
 Due to changes in practices in the dairy industry, such as improved bacterial 
quality, extended storage and the introduction of high-temperature processed milk 
(plasmin is very heat stable), plasmin has gained an increased significance since its 
relationship with microbial proteases provides a means to control its levels to benefit 
the quality of dairy products (Kelly and McSweeney, 2003). 
 Bovine plasminogen is a single-chain glycoprotein containing 786 amino acid 
residues, with a molecular mass of 88 kDa. Plasminogen is converted to plasmin by 
cleavage of the Arg557–Ile558 bond by specific proteinases. Three elements of the 
plasmin system (plasmin, plasminogen and PAs) have been reported to have very 
similar and relatively high heat stabilities. For plasmin and plasminogen, this high heat 
stability is attributed to protection by milk proteins, such as casein (Grufferty and Fox, 
1988). Plasmin contributes to primary proteolysis in cheese, especially high-cooked 
varieties in which the coagulant is extensively denatured; it may cause age gelation of 
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ultra high temperature (UHT) sterilized milk; and reduces the yield of cheese and 
casein owing to the loss of proteose peptones in whey (Rollema et al., 1981). 
 
3.4.2. Cathepsin D 
 The second proteinase identified in milk was cathepsin D, which is presumably 
a lysosomal enzyme (Larsen et al., 1996). As with plasmin, cathepsin D is part of a 
complex system, including inactive precursors (Hurley et al., 2000). The major form of 
cathepsin D in milk is the inactive zymogen, procathepsin D (the proenzyme of 
cathepsin D), although milk also contains low levels of the mature forms of the enzyme 
(Larsen et al., 2000).  
 The level of cathepsin D in milk is correlated significantly with the somatic cell 
count (SCC), although it is not clear whether this reflects increased production of 
cathepsin D and/or increased activation of precursors (Hurley et al., 2000). Cathepsin 
D has a pH optimum of 4 and a molecular mass of 36 kDa and can degrade all milk 
proteins except -lactoglobulin (Larsen et al., 1996). It is completely inactivated by heat 
treatment of 70ºC for 10 min at pH 4 in acetate buffer and by pasteurization at 65ºC for 
30 min in skim milk (Chen et al., 2003). Because of this relatively low heat stability, 
even in milk, cathepsin D has not been regarded as an important enzyme in 
pasteurized milk and milk products.  
 
3.5. Lipases and esterases 
 Lipolytic enzymes can be defined as carboxylesterases that hydrolyse 
acylglycerols (Beisson et al., 2000). Those that hydrolyse acylglycerols of less than 10 
carbon-chain fatty acids are the esterases, or carboxylases (EC 3.1.1.1); those that 
hydrolyse acylglycerols of over or equal  10 carbon-chain fatty acids are the lipases, or 
triacylglycerol acylhydrolases (EC 3.1.1.3). Esterases are active in aqueous solutions, 
while true lipases are more active at lipid–water interfaces rather than in the aqueous 
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phase and most are also capable of hydrolyzing esterase substrates (Chen et al., 
2003). 
 Lipoprotein lipase (LPL) accounts for most of the lipolytic activity in bovine milk 
(Olivecrona et al., 2003) and shares about 30% sequence identity with pancreatic 
lipase, which is regarded as a typical lipase (Fox and Kelly, 2006a) (Table 3). LPL is a 
dimer of glycoprotein chains (two N-linked oligosaccharides), each of 42 kDa, and 
contains 8.3% carbohydrate (Olivecrona et al., 2003). This enzyme is synthesized in 
mammary gland secretory cells and its level in bovine milk is dependent on the breed, 
stage of lactation, diet and nutrition, the season and milk production level (Deeth, 
2006). 
 LPL can form large aggregates, regardless of ionic strength, and yet retain an 
active conformation (Olivecrona and Bengtsson, 1984). Moreover, this enzyme is 
relatively unstable to heat. High-temperature, short-time (HTST) pasteurization (72ºC 
for 15 s) inactivates most, if not all, of the enzyme in milk (Deeth, 2006), and therefore 
LPL causes little, if any, lipolysis in pasteurized milk and products derived from 
pasteurized milk (Chen et al., 2003). In most milk samples, LPL causes hydrolytic 
rancidity only if the MFGM is damaged, e.g., by agitation, foaming, cooling/warming, 
freezing or homogenization (Chen et al., 2003).  
 Esterases are distinguished from lipases by their preference for soluble rather 
than emulsified ester substrates. Milk contains several esterases (Kitchen, 1985; Chen 
et al., 2003), the most significant of which are acylesterases (EC 3.1.1.7), 
cholinesterase (EC 3.1.1.8) and carboxylesterase (3.1.1.1). 
 
3.6. Amylase 
 Amylase in milk is indigenous and -amylase is the principal enzyme, with a 
lesser amount of -amylase; the enzymes partition mainly into skimmed milk and whey 
(Fox and Kelly, 2006a). -amylase in milk is similar to salivary amylase. Amylase is 
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quite labile to heat and loss of amylase activity was proposed as a reliable index of the 
intensity of heat treatment applied to milk. Since bovine milk contains no starch and 
only low levels of oligosaccharides, the function of amylase in milk is unclear.  
 
3.7. Alkaline phosphatase 
 Alkaline phosphatase (AlP; EC 3.1.3.1) is a membrane-bound glycoprotein that 
is widely distributed in animal tissues and in microorganisms (Table 3). It is a very 
important enzyme in clinical chemistry, being its activity in various tissues an indicator 
of diseased states. Nevertheless, its physiological roles are still unclear. 
 The AlP activity of bovine milk varies considerably between individuals, and 
throughout lactation; activity varies inversely with milk yield but is independent of fat 
content, breed and feed (Fox and Kelly, 2006b). AlP is concentrated in cream and is 
released into buttermilk on churning. 
 AlP is a homo-dimer of two identical sub-units, each of molecular mass 85 kDa; 
it contains four atoms of Zn which are essential for activity and is also activated by 
Mg2+ (Fox and Kelly, 2006b). AlP is inhibited by metal chelators; the apo-enzyme may 
be reactivated by the addition of one of a number of metals, which is used as the 
principle of methods to determine very low concentrations of zinc in biological systems. 
It is also inhibited by inorganic phosphate.  
 
3.8. Acid phosphatase  
 Acid phosphomonoesterase (AcP; EC 3.1.3.2) in milk has an optimal pH of 4.0 
and is very stable to heating (for complete inactivation heating at 88ºC for 10 min is 
required). The enzyme is not activated by Mg2+ (as is AlP), but it is activated slightly by 
Mn2+ and is very strongly inhibited by fluoride (Fox and Kelly, 2006b). 
 About 80% of the AcP in cow milk is found in the skimmed milk but the specific 
activity is higher in cream. There is only one isozyme of AcP in milk that is strongly 
attached to the MFGM and is not released by non-ionic detergents (Kitchen, 1985). 
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Furthermore, about 40% of the AcP in skim milk partitioned into the whey on rennet 
coagulation. 
 The AcP isolated from skim milk is a glycoprotein with a molecular mass of 42 
kDa and an isolelectric point of 7.9. It is inhibited by many heavy metals, oxidizing 
agents, orthophosphates and polyphosphates and is activated by thiol-reducing agents 
and ascorbic acid; it is not affected by metal chelators (Andrews, 1976). This enzyme 
contains a high level of basic amino acids and no methionine.  
 Although AcP is present in cow milk at a much lower level than AlP, its greater 
heat stability and lower pH optimum may make it technologically significant. The 
suitability of AcP as an indicator enzyme for super pasteurization of milk has been 
reported although it is not as useful as other alternatives (e.g. -GGT or LPO) (Andrews 
et al., 1987). 
 
3.9. Ribonuclease 
 Ribonucleases (RNase) catalyze cleavage of the phosphodiester bond between 
the 50-ribose of a nucleotide and the phosphate group attached to the 30 position of 
ribose of an adjacent pyrimidine nucleotide, forming a 20, 30 cyclic phosphate, which is 
then hydrolyzed to the corresponding 30-nucleotide phosphate. RNases of various 
origins and with different biological functions have been characterized. RNase occurs 
in various tissues and secretions, including milk (Fox and Kelly, 2006b). 
 RNase in cow milk is optimally active at pH 7.5 and is more heat-stable at acid 
pH values than at pH 7. Little or no RNase activity survives UHT sterilization (121ºC for 
10 s) but about 60% survives heating at 72ºC for 2 min (Meyer et al., 1987) or at 80ºC 
for 15 s (Griffiths, 1986). RNase activity in raw or heat-treated milk is stable to repeated 
freezing and thawing and to frozen storage for at least a year (Meyer et al., 1987). It 
has been suggested that RNase can inhibit bacteriophage, which can inhibit the growth 
of starter cultures in cheese making. Otherwise RNase has no technological 





 N-acetyl--D-glucosaminidase (NAGase; EC 3.2.1.30) hydrolyzes terminal, non-
reducing N-acetyl--D-glucosamine residues from N-acetyl--D-glucosaminides, 
including glycoproteins and fragments of chitin. However, NAGase is not specific for N-
acetyl--D-glucosaminides; since it can also hydrolyse N-acetyl--D-galactosaminides. 
 NAGase is thought to be a lysosomal enzyme that originates principally from 
mammary gland epithelial cells and, to a lesser extent, from somatic cells. More than 
95% of NAGase in cow milk is in the skimmed milk. The enzyme is optimally active at 
50ºC and pH 4.2 (Fox and Kelly, 2006b).  
 NAGase is inactivated by high temperature-short time (HTST) pasteurization 
and it has been proposed as a suitable indicator enzyme for assessing heat treatment 
in the range 65–75ºC during 15 s (Andrews et al., 1987). 
 
3.11. Lysozyme 
 Lysozyme (EC 3.1.2.17) is a widely distributed enzyme that lyses certain 
bacteria by hydrolyzing the (1-4)-linkage between muramic acid and N-acetyl-
glucosamine of mucopolysaccharides in the bacterial cell wall. Although lysozyme is a 
lysosomal enzyme, it is found in soluble form in many body fluids and the lysozyme in 
milk is usually isolated from whey, indicating that it is in solution, like other lysosomal 
enzymes such as cathepsin D (Fox and Kelly, 2006b).. 
 The bovine milk lysozyme presents an optimum pH of 6.4, a molecular weight of 
18 kDa and its amino acid composition and immunological properties are considerably 
different from those from other species (e.g. human or equine milk). The amino acid 
sequence of lysozymes is highly homologous with that of -lactalbumin. All lysozymes 
are relatively stable to heat at acid pH values but are relatively labile at pH above 7. 
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More than 75% of the lysozyme activity in bovine milk survives heating at 75ºC during 
15 min or 80ºC during 15 s and therefore it is not affected by HTST pasteurization.  
 Lysozyme’s most probable physiological role is to act as a bactericidal agent. 
One might expect that, owing to its bactericidal effect, indigenous milk lysozyme would 
have a beneficial effect on the shelf-life of milk; nevertheless such effects do not 
appear to have been reported. Exogenous lysozyme may be added to milk for many 
cheese varieties (e.g., Gouda, Edam, Emmental, Parmigiano Reggiano) as an 
alternative to KNO3 to prevent the growth of Clostridium tyrobutyricum which causes 
late gas blowing and off-flavors.  
 
3.12. -glutamyl transferase  
 -glutamyl transferase (-GGT; EC 2.3.2.2) catalyses the transfer of -glutamyl 
residues from -glutamyl-containing peptides. In milk, -GGT is found in the membrane 
material in skim milk (70%) or in the MFGM, from which it can be dissociated by 
detergents or organic solvents. The enzyme has a molecular mass of 80 kDa and 
consists of two subunits of 57 and 25 kDa, both of which are glycoproteins 
(Baumrucker, 1980). The enzyme, which associates strongly, is optimally active at pH 
8.5–9 and 45ºC and has an isoelectric point of 3.9. It is strongly inhibited by 
diisopropylfluorophosphate, iodoacetamide and metals (Farkye, 2003). -GGT activity 
in human and bovine milk varies during lactation, being highest in colostrum. 
 -GGT has a role in the regulation of cellular glutathione (GSH) and may be 
involved in the transport of amino acids from blood into the mammary gland via the so-
called -glutamyl cycle and thus may be involved in the biosynthesis of milk proteins 






3.13. Superoxide dismutase 
 Superoxide dismutase (SOD; EC 1.15.1.1) scavenges superoxide radicals. The 
H2O2 formed may be reduced to water and oxygen by catalase, peroxidase or a 
suitable reducing agent. SOD has been identified in many animal and bacterial cells 
being its biological function to protect tissue against free radicals of oxygen in 
anaerobic systems. There are four isoforms of SOD, Cu/Zn-SOD, extracellular (EC) 
SOD, Mn-SOD and Fe-SOD. Cu/Zn-SOD is the most common form in mammals and 
has been isolated from a number of tissues, including bovine erythrocytes. The 
enzyme, which is very stable in 9M urea at neutral pH, consists of two identical 
subunits of molecular mass 16 kDa (153 amino acid residues), held together by one or 
more disulphide bonds (Hara et al., 2003). Mn-SOD and EC SOD are tetrameric 
enzymes with subunits of molecular mass 20 and 35 kDa, respectively. 
 
3.14. Sulphydryl oxidase 
 Sulphydryl oxidase (SHOx; EC 1.8.3-) catalyses the oxidation of SH groups of 
cysteine, GSH and proteins to disulphides. The enzyme is widely distributed in cell 
membranes, including those of the mammary gland, kidney, pancreas and intestine. 
SHOx is a glycoprotein (10% carbohydrate) containing 0.5 atoms of Fe per monomer 
(89 kDa). The enzyme is optimally active at pH 7 and 35ºC and is inhibited by metal 
chelators and SH-blocking reagents. 
 SHOx oxidizes reduced RNase and restores enzymatic activity, suggesting that 
its physiological function is the formation of specific disulphide bonds during the post 
synthesis processing of proteins. Its significance in the dairy industry is its ability to 
oxidize SH groups exposed and activated during high-temperature processing and 
which are responsible for the cooked flavor in such products (Swaisgood, 2003). 
Apparently, oxidation of the SH groups renders the product more stable to lipid 





 Aldolase (EC 4.1.3.13) reversibly hydrolyses fructose 1,6-diphosphate to 
dihydroxyacetone phosphate and glyceraldehyde-3-phosphate. It is a key enzyme in 
the glycolytic pathway. Its presence in cow milk has been reported, and although most 
(66%) of the aldolase in milk is in the skim milk fraction (Kitchen et al., 1970), it is 
concentrated in the cream (Keenan and Mather, 2006). The aldolase is located in the 
cytoplasm of the mammary cells, from which the enzyme in milk presumably originates, 
although some may be from blood. Furthermore, it has been suggested that aldolase 
plays a role in flavor development in dairy products.  
 
3.16. Glutathione peroxidase 
 Glutathione peroxidase (GSH; EC 1.11.1.9) is widespread in the cytoplasm of 
animal tissues, especially erythrocytes. Its function is to protect the cell against the 
damaging effects of peroxides, as part of an anti-oxidative system which includes SOD 
(Avissar et al., 1991). GSH is a tetrametric protein of four identical subunits (21 kDa), 
each of which contains one atom of selenium (Se). The molecule has been well 
characterized, including elucidation of its primary, secondary and tertiary structures (Liu 
and Luo, 2003).  
 GSH has no known enzymatic function in milk, in which it binds 30% of the total 
Se, an important trace element in the diet. The level of GSH in milk varies with the 
species and diet (Farkye, 2003). 
 
4. Milk hormones and growth factors 
 A clear division between milk hormones, cytokines and growth factors is 
currently missing (Gauthier et al., 2006). All these molecules are important for the 
growth, maturation or repair of different cell types in the neonate and/or adult. 
Moreover, all of these growth-promoting factors are signaling molecules released by 
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cells to communicate with each other. Briefly, hormones are substances that are 
released into the extracellular medium by the cells of a given tissue, to be transported 
to a new site of action (endocrine function), where they induce a specific response. The 
distinction between cytokines and growth factors is not straightforward since some 
growth factors (e.g. transforming growth factor beta; TGF-) have also been reported 
as cytokines by many authors (Gauthier et al., 2006). Cytokines are proteins or 
glycoproteins produced by many cell types that have profound bioactive effects on 
other cells within a short distance at low concentrations (Playford et al., 2004). As a 
result, the cytokine effects are local and these agents are involved in autocrine or 
paracrine functions. Examples of cytokines include the interleukins (IL) series, tumor 
necrosis factors (TNF) and interferon (IFN). Growth factors are proteins or polypeptides 
that bind to specific receptors triggering intracellular secondary messengers, ultimately 
resulting in cellular proliferation and/or differentiation (Michaelidou and Steijns, 2006). 
 Milk contains more than 50 growth factors and hormones, being their 
concentrations much lower than those of immunoglobulins or lactoferrin (Michaelidou 
and Steijns, 2006). Whereas bovine colostrums may contain high levels of cytokines 
such as interleukin-1 (IL-1), IL-6, tumor necrosis factor (TNF-), interferon- (INF-), 
and IL-1 receptor antagonist, their levels in mature milk are remarkably lower 
(Hagiwara et al., 2000). Whey has also been identified as a source of growth factors 
with potent and proven bioactivity (Smithers, 2004). Examples of growth factors 
identified in milk include insulin-like growth factor (IGF-I and II), platelet-derived growth 
factor (PDGF), fibroblast growth factor (FGF), transforming growth factor (TGF-) and 
betacellulin (Dunbar et al., 1999; Elfstrand et al., 2002; Pakkanen and Aalto, 1997; 
Rogers et al., 1995). Since these compounds are potent growth stimulants and 
mediators for a range of mammalian cells, they constitute potential bioactive 
ingredients in a range of biomedical and functional foods (Smithers, 2004). Milk derived 
TGF- might be exploited in functional foods for the infant or during therapies for 
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specific intestinal diseases or cancers (Donnet-Hughes et al., 2000). Milk-derived 
products are already in clinical use for the treatment of inflammatory bowel disease; 
casein-based enteral feeds are used for the treatment of Crohn disease (Beattie et al., 
1998; Donnet-Hughes et al., 2000) and their efficacy might be due to the presence of 
growth factors (Playford et al., 2000). Also, results from animal and human trials with a 
growth factor extract from Cheddar cheese whey targeting oral mucositis and chronic 
ulcers were very promising (Smithers, 2004). Dairy derived preparations appear to be 
an attractive therapeutic option (Regester and Belford, 1999) because they contain 
many different growth factors in a formulation that provides additive or synergistic 
activity and inherent protection against proteolytic digestion. Besides, such 
preparations have the advantage of being perceived as ‘‘natural’’ products, which may 
result in greater patient acceptance and compliance (Playford et al., 2000). 
 
4.1. Hormones 
 Milk contains several hormones at trace levels that have limited nutritive or 
diagnostic value. However, many studies regarding the hormones’ physiological roles 
in human and bovine milk have been conducted (Koldovsky and Thornburg, 1987; 
Grosvenor et al., 1993). Hormones in milk originate from the blood and are secreted in 
milk through an active transport within the mammary gland. Also, some hormones can 
be synthesized by the mammary gland and excreted to milk. Table 5 summarizes the 
main hormones that have been identified in bovine milk, as well as its concentration 
ranges (Jouan et al., 2006). Most hormones reported in milk are classified into four 
main groups, such as gonadal, adrenal, pituitary and hypothalamic hormones. Other 
molecules, such as proteins related to the parathyroid hormone have also been 
reported as hormones. 
 
4.1.1. Gonadal hormones 
29 
 
 The gonadal hormone group includes estrogens, progesterone and androgens, 
being the androgens the least studied hormones. Since the amount of hormones in 
milk and milk products is very low, their accurate quantification remains a challenge. 
Several techniques have been proposed for this purpose, such as colorimetry, 
spectrofluorometry, gas chromatography and high-pressure chromatography, and 
radioimmunoassay. The concentrations of estrogens, namely 17-estradiol, estrone 
and estriol in milk and several dairy products have been reported (Wolford and 
Argoudelis, 1979). The cow milk fat fraction was found to contain 65% of 17-estradiol 
and 80% of estrone. The occurrence of estrogens in both butter and skim milk clearly 
indicates a distribution of those steroids between the lipid and serum phases of milk. 
Estrone was found to be the predominant estrogen in milk, and it is well known that 
estrogen concentrations are related to gestation and reproductive cycle. Regarding 
progesterone levels in milk, they have been found to be related to pregnancy and 
parturition (Comin et al., 2005). In cow milk, progesterone concentrations are 
determined by gas chromatography and are around 0.3-0.4 pg mL-1 (Darling et al., 
1974). The progesterone concentrations were found to be higher in cream than in skim 
milk. Ginther and co-workers (1976) determined the progesterone contents of several 
cow dairy products, namely 11.4 ng mL-1 in whole milk, 4.7 ng mL-1 in skim milk, and 
58.8 ng mL-1 in cream.  
   
4.1.2. Adrenal gland hormones 
 Adrenal gland hormones consist essentially of the glucocorticoids that have 
been identified in bovine milk in concentrations between 0.7 and 1.4 ng mL-1 
(Gwazdauskas et al., 1977). No remarkable differences have been found between 
whole and skim milk. Cortisol and corticosterone are the main glucocorticoids in blood 
plasma of cows (Tucker and Schwalm, 1977). During lactation, the glucocorticoid 
concentrations in milk only represent 4% of the blood plasma concentrations, 
suggesting that only a small amount is transferred to the milk. Glucocorticoids are not 
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concentrated in cream, as is the case of estrogens. In bovine milk, corticosteroids are 
equally distributed between caseins and whey protein fractions. Glucocorticoids 
possibly act in conjunction with other hormones to maintain lactation and their effects 
are mediated by specific receptors. Furthermore, there seems to be a reduction of the 
glucose uptake by the mammary gland due to the presence of glucocorticoids, thus 
suggesting that the milk production is regulated by these hormones. 
 
4.1.3. Pituitary hormones 
 Two hormones have been identified in the category of pituitary hormones, 
namely prolactin and the growth hormone. Prolactin concentrations ranging 5 to 200 ng 
mL-1 were detected by radioimmunoassay in bovine milk (Malven and Mc Murty, 1974). 
It has been suggested that prolactin concentrations vary seasonally being higher in the 
summer, and a direct effect of storage temperature of the milk appears to affect this 
hormone concentration. Lower temperatures present a negative impact on prolactin 
concentrations. Kacsoh and collaborators (1991) reported that part of the prolactin 
content of milk is associated with the milk fat globules, thus 60% of the prolactin is 
removed from milk during the centrifugal separation of fat. This hormone is thought to 
originate from blood plasma and its biological functions are not well known. The growth 
hormone or somatotropin has been detected in milk at concentrations lower than 1 ng 
mL-1 (Torkelson, 1987). Regarding its biological functions, somatotropin is thought to 
be acting on the mammary gland by means of specific receptors. Furthermore, this 
hormone was also found to increase the concentration of insulin-like growth factor-1 
(IGF-I) in epithelial cells of the mammary gland of lactating cows (Glimm et al., 1988). 
 
4.1.4. Hypothalamic hormones 
 The group classified as hypothalamic hormones includes the gonadotropin-
releasing hormone, luteinizing hormone-releasing hormone, thyrotropin-releasing 
hormone and somatostatin. All these hormones have been detected and quantified in 
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bovine milk mainly using radioimmunoassay. Gonadotropin-releasing hormone content 
in milk is 5-6 times greater than in blood plasma (Baram et al., 1977). The hormone 
might be from an extra-hypothalamic origin but it is more likely coming from an active 
transport by the mammary gland. Amarant and collaborators (1982) determined the 
luteinizing hormone-releasing hormone content in milk and colostrums. This hormone 
may originate from the blood and be concentrated in the mammary gland by an active 
process or be of an extra-hypothalamic origin. The same authors also measured 
thyrotropin-releasing hormone in milk and colostrum. As for the other hypothalamic 
hormones, their origin in milk is unclear. The occurrence of somatostatin in bovine milk 
has been demonstrated by enzyme immunoassay on fat and casein free milk 
(Takeyama et al., 1990). Its concentrations in milk vary between 10 and 30 pmol/L and 
it does not seem to be affected by parturition. 
 
4.1.5. Other hormones 
 As previously mentioned, other molecules, such as proteins related to the 
parathyroid hormone, insulin, calcitonin, bombesin, erythropoietin and melatonin, have 
also been identified in milk although they are less known and characterized. Many 
authors have mentioned that parathyroid hormone-related protein is present in bovine 
milk (Budayr et al., 1989; Ratcliffe et al., 1990). Curiously the concentrations of this 
hormone in both fresh and pasteurized milk have been found to be similar, thus 
suggesting that this hormone is heat-stable. The physiological functions of this 
hormone have not been clearly established. Produced by the mammary gland, this 
hormone might be involved in the transport of calcium from blood plasma to milk. 
Regarding insulin, its concentrations in milk were found to vary during pre-partum, 
post-partum and after parturition (Malvern, 1977). In colostrum its content is between 
0.67 and 5.0 nM, which is 100-fold higher than the concentration in the blood plasma 
(Ballard et al., 1982). Moreover, calcitonin concentrations in human milk have been 
estimated at 700 ng mL-1 and this hormone has been found to inhibit the liberation of 
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prolactin (Koldovsky, 1989). As for bombesin, it is known to influence the gastric 
hormonal secretions following ingestion (Lazarus et al., 1986). Satiety, blood sugar 
concentrations, gut acidity and concentrations of some gastro-intestinal hormones are 
known to be influenced by bombesin. Bombesin has been found in human milk, bovine 
milk, milk powder and whey (Koldovsky, 1989). Furthermore, no analytical data 
regarding the erythropoietin content in bovine milk are available, although this hormone 
has been identified in human milk (Grosvenor et al., 1993). Finally, melatonin is a 
hormone synthesized by the pineal gland in a diurnal pattern reflecting photoperiodicity. 
Melatonin has been found in human, bovine and goat milk (Eriksson et al., 1998; 
Valtonen et al., 2003) at a low concentration.  
 
4.2. Growth factors 
 The most abundant growth factors in bovine milk and colostrum are insulin-like 
growth factor I (IGF-I), transforming growth factor (TGF)-2, some members of the 
epidermal growth factor (EGF) family and fibroblast growth factor (FGF2) (Grosvenor et 
al., 1993; Pakkanen and  Aalto, 1997). Table 6 summarizes the experimental data 
available on the content of some of these growth factors in bovine milk. The 
concentrations found in colostrum are generally higher than those in milk, except for 
betacellulin (BTC), where it appears to be equivalent (Pouliot and Gauthier, 2006). 
Quantitatively, the relative concentrations of growth factors in milk are IGF-I  TGF-2  
EGF  IGF- II   bFGF.  
 The main biological functions of milk growth factors have been extensively 
reviewed by Gauthier and co-workers (2006). Briefly, EGF and BTC are members of 
EGF family that were detected in milk products in sufficient amount to induce 
physiological effects (Dunbar and Goddard, 2000). They stimulate the proliferation of 
epidermal, epithelial and embryonic cells; inhibit the secretion of gastric acid and 
promote wound healing and bone resorption.  
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 The TGF- family comprises multifunctional growth and differentiation factors 
that act on most cell types with activities dependent on the cell type, stage of 
proliferation and environment (Massague, 1990), thus playing an important role in 
embryogenesis, tissue repair, formation of bone and cartilage, and in the control of the 
immune system. TGF-2 is the predominant form of the TGF family members found in 
milk products, and although its physiological function is unknown some authors 
suggested that it could be a mediator of mucosal immunity or gut epithelial 
differentiation in neonates (Cox and Burk, 1991; Jin et al. 1991). TGF-s stimulates the 
proliferation of some cells, especially in connective tissue, whereas they act as growth 
inhibitors of some other cells, such as lymphocytes and epithelial cells.  
 The insulin-like growth factors, IGF-I and IGF-II, stimulate the proliferation of 
many cell types (Jones and Clemmons, 1995). IGF-I stimulates cellular growth, 
development and differentiation. Furthermore, IGF-I stimulates glucose uptake and the 
synthesis of glycogen. Administration of IGFs to humans causes hypoglycemia (Guler 
et al., 1987), improvement in nitrogen balance (Clemmons et al., 1992), lowering of 
cholesterol and potassium (Moscatelli, 1987), and improvement in renal functions 
(Guler et al., 1989; Hirschberg et al., 1993).  
 Fibroblast growth factor (FGF2) can exert multiple functions on a variety of 
cells. It has been reported to stimulate proliferation, migration and differentiation of 
endothelial cells, fibroblasts and epithelial cells (Chen et al., 2004). This growth factor 
also promotes angiogenesis, normal wound healing, tissue development, 
hematopoiesis and the synthesis of collagen and fibronectin. It has been suggested 
that FGF2 in milk might be bound to the heparan sulfate proteoglycan in the milk fat 
globule membrane (Hironaka et al, 1997).  
 
5. Milk organic acids 
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 Most work that has been recently conducted regards the presence of fatty acids 
in milk (e.g. conjugated linoleic acid (CLA), linoleic acid, myristic, plamitic, butyric and 
stearic) (Parodi, 1999; Mansbridge and Blake, 1997) and less attention has been given 
to the organic acids (e.g. citric, lactic, acetic) (Mullin and Emmons, 1997). Citric acid is 
the predominant organic acid in milk. During storage it disappears rapidly as a result of 
the action of bacteria. Other acids (lactic, acetic) are degradation products of lactose. 
The occurrence of orotic acid, an intermediary product in the biosynthesis of pyrimidine 
nucleotides, is specific for milk. Orotic acid, as well as total creatinine and uric acid are 
suitable indicators for the determination of the proportion of milk in foods. The contents 
of orotic acid, creatinine and uric acid in milk vary among the different species. For 
example, the content in orotic acid is low in buffalo milk (19.6 g/100 ml) as compared 
to cow milk (52.6 g/100 ml), while creatinine is higher (246 mg/100 ml versus 167 
mg/100 ml) and uric acid is the same (0.26 mg/100 ml) (Park and Haenlein, 2006).  
 Raw milk produced under normal conditions develops acidity. It has long been 
recognized that highly acid milk does not putrefy. Therefore, allowing milk to develop 
acidity naturally preserves the other milk constituents. Fresh bovine milk is particularly 
suitable as a fermentation substrate for most microorganisms, since it contains 5% 
lactose, 3.3% protein, has a water activity near 1.0 and a pH of 6.7. Although milk from 
other species present different compositions of protein and lactose, they are also 
suitable for microbial growth (Park and Haenlein, 2006). Milk samples from normal 
healthy mammary glands contain many strains of bacteria (Haug et al., 2007).  
Bacteria in milk are responsible for acid development. They produce acid by the 
anaerobic breakdown of lactose to lactic acid and other organic acids. A number of 
sugar fermentations depending on the microorganism involved and the end products 
have been reported in milk. For example, if only streptococci and lactobacilli are 
present, then the end product will be lactic acid. The lactic acid fermentation is the 
most important one in milk and is central to many processes (Mullin and Emmons, 
1997). Lactic acid bacteria are saccharolytic and fermentative, and therefore are ideally 
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suited for growth in milk. In general, they will out-compete other microorganisms for 
lactose, and due to acidification they will produce an unfriendly environment for 
competitors. Therefore, when properly made, cultured dairy products (fermented milks) 
have long shelf-lives and, although growth of acid-tolerant yeast and molds is possible, 
growth of pathogens rarely occurs. Propionibacteria will ferment lactose producing 
lactic acid, propionic acid, acetic acid and carbon dioxide. Propionic fermentation is a 
mixed-acid fermentation and is used in the manufacture of Swiss cheese varieties. 
Yeasts, such as Candida and Torula, will produce ethanol and carbon dioxide. Alcohol 
fermentation can be used to prepare certain fermented milks and also to make ethanol 
from whey. On the other hand, coliform fermentation can also occur with the production 
of lactic acid, acetic acid, ethanol, carbon dioxide and hydrogen. This type of 
fermentation is an example of undesirable spoilage fermentation. Large numbers of 
coliform bacteria in milk indicates poor hygiene. The coliform fermentation disrupts 
lactic acid fermentation and also causes spoilage in cheese. The type of fermentation 
obtained will depend on the numbers and types of bacteria in milk, storage temperature 
and the presence or absence of inhibitory substances. Different bacteria may be used 
for fermentation, giving products special flavor and aroma, and with several potential 
health beneficial metabolites (Rossland et al., 2005). Fermented milks (buttermilk, kefir, 
coumis, aigar, among others) are nutritious foods and many have been reported as 
possessing medicinal properties (Vinderola et al., 2005; Branca and Rossi, 2002; De 
Vrese et al., 2001; Sanggaard et al., 2004).  
Organic acids play an important role in fermented milks and cheese, and can be 
changed due to technical options in the process. Park and Guo (2006) reviewed the 
organic acid composition of several types of goat cheese depending on the processing. 
For example, for plain soft goat cheese they found differences in tartaric, formic and 
uric acid contents between fresh and frozen-thawed treatments. Freezing caused an 
increase in formic and uric acids and a decrease in tartaric acid. These changes in 
organic acid contents of the plain soft goat cheese are in contrast with the results 
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reported by Califano and Bevilacqua (1999) that found no significant effect of freezing 
on the variations in organic acid contents of cow milk Mozzarella cheese. Also, Park 
and Guo (2006) reported that aging (refrigerated storage at 4ºC for 28 days) of plain 
soft goat cheese promoted changes in only three acids (orotic, malic and butyric). In 
Montery Jack cheese, frozen and thawed cheese had higher acetic, butyric, citric, 
malic, propionic, and pyruvic acids compared to the unfrozen control cheese. The 
levels of acetic, butyric, malic, and orotic acids were elevated by aging time.  
 
6. Future perspectives and concerns 
 Milk and milk products are commonly used in many food regimens, and 
although the operations for their processing are known and optimized, many 
challenges persist (Villamiel et al., 2009). Within modern societies the milk has to be 
treated in different ways to be kept for several days. This processing includes steps 
that may be of concern. In fresh milk each lipid globule is surrounded by an apical 
plasma membrane from the mammary epithelial cell. It is not known, although debated, 
whether the milk homogenization, when the fat globules with their globule membrane 
are broken up into many new small lipid droplets with just a small fragment of the 
originating membrane, might have health implications (Haug et al., 2007). Additionally, 
proteins and peptides are heat sensitive, and their bioactivity may be reduced by 
pasteurization of milk. Heating of milk may also result in the formation of potentially 
harmful new products, e.g. reaction products between carbohydrates in milk with 
proteins (Lund et al., 2005). Also, the amount of some vitamins and antioxidants will be 
reduced by heating. Glutathione may easily be destroyed during storage (Ankrah et al., 
2000). Therefore, the dairy industry has to deal with the important challenge of treating 
milk in such a way that preserves its vitamins, proteins and peptides. Most of the new 
technologies currently used are not completely new and they have been explored in the 
past but with limited success. However, the technical-scientific progress together with 
the consumer demands for minimally processed foods has led to their renaissance. 
37 
 
Some dairy industries currently filter milk using membrane processes instead of using 
pasteurization, and the use of non-thermal processing technologies may yield health 
benefits (Haug et al., 2007). New technologies used in the milk processing for the 
inactivation of microorganisms and enzymes involve microwaves, high pressure, 
pulsed electric fields, microfiltration, innovative steam injection systems and combined 
technologies (Villamiel et al., 2009). 
 Regarding novel production methods it is important to mention that systems, 
synthetic and metabolic engineering will be in the near future key players for the 
development of improved and safe microbial cell factories that will enable the 
production of specific enzymes, vitamins or minor components (Park and Lee, 2008; 
Brenner et al., 2008). Using these tools it will be possible to produce higher amounts of 
such components, produce them in such a way that recovery is easier and produce 
differentiated compounds, thus revolutionizing the field of functional foods.  
 On the other hand, new perspectives also involve the development of novel 
formulations targeting specific consumer groups, such as newborns, elderly, diabetics, 
among others. Nowadays, the use of minor milk components to enrich food products 
and to develop new ones holds a big promise towards the emergent fields of 
personalized nutrition and functional foods (Stover and Garza, 2002; Kussmann and 
Fay, 2008; Kaput, 2008). Nevertheless, it is extremely important that the benefits 
claimed for such components are proved using living systems. There is still a lot of 
knowledge on the biological activity of the minor milk constituents lacking and new 
methodologies ought to be developed. Also, the study of the mechanisms of interaction 
of such components with cell receptors and/or specific genes is still limited and the 
omics techniques can be very useful to gather this sort of information (Ferguson, 2006; 
van Ommen and Stierum, 2002; Muller and Kersten, 2003). 
 Several challenges and concerns regarding the potential use and understanding 
of minor milk constituents, enzymes, hormones, growth factors, and organic acids, still 
need to be addressed. Some examples include technological concerns, such as the 
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impact of milk enzymes on the quality of fermented milks; the impact of technological 
developments in thermal processing on milk constituents, specifically on enzymes, 
relative to the sensory quality of milk; and the impact of membrane processes on 
enzyme activities in dairy products; and many others. On the other hand, interesting 
challenges ought to be pursued, such as those related to the commercial availability of 
certain milk enzymes which have not found widespread application in industry; the 
potential significance of enzymes and other minor constituents from colostrum; the 
potential nutraceutical significance of such milk constituents; the relationship between 
some enzyme activities and the sensory quality of stored milk and means to control the 
activity of some enzymes.  
Finally, as milk composition varies broadly with several factors such as genetics 
(e.g. species and breed), stage of lactation, health status and environmental factors 
(e.g. feed, climate and method of milking), manipulating these factors constitutes a 
“natural” way of changing the minor constituents’ contents in milk. Genetic manipulation 
of livestock has been limited to the permanent addition of genes of clinical interest. 
Nevertheless, researchers have been exploring the utility of genetically engineered 
cattle as a means of altering milk composition to improve the functional properties of 
milk, increasing marketability (Karatzas and Turner, 1997). Improvements would 
include increasing the concentration of valuable components in milk (e.g., casein), 
removing undesirable components (e.g., lactose), or altering composition to resemble 
that of human milk as a means of improving human neonatal nutrition. On the other 
hand, milk composition can be altered by nutritional management or through the 
exploitation of naturally occurring genetic variation among cattle (crossbreeding or 
selection). Additionally, on-farm methods including rumen modification, trait selection 
and rations can be used to change milk composition (Haenlein and Anke, 2011; 
Knowles et al., 2006). Through these methods it has been possible to increase 
concentrations of calcium, selenium, iodine, iron and cobalt/Vitamin B12 in milk. For 
example, the conjugated linoleic acid content in milk fat can be modified by feeding that 
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influences the pattern of fat precursors the mammary gland removes from blood for fat 
synthesis (Mel’uchov´a et al., 2008). Variation in conjugated linoleic acid content in milk 
of ruminants appears to be minimally influenced by the stage of lactation, parity and 
breed (Sanz Sampelayo et al., 2007). Nevertheless, diet is the most important factor 
influencing milk conjugated linoleic acid concentration. The conjugated linoleic acid 
concentration in milk is higher in pasture-raised animals than in those fed with dry 
diets, and it decreases with increasing growth stage of forage or maturity. Off-farm 
alternative approaches to manipulate milk composition might be less desirable. For 
instance, fortification at the processor with trace elements and vitamins by way of post-
harvest or supplements is common, and usually inexpensive, but many consumers 
prefer not to consume these additives (Cox, 2008), some legal definitions of fresh milk 
preclude addition of fortificants, and some markets permit only ‘unadulterated’ foods 
(e.g., exported infant formula). Regardless of method, manipulations will be appropriate 
only if they suit typical farming practice and do not perturb other product qualities such 
as safety, shelf life, texture or taste. 
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Table 1. Contents of some minor constituents in milk from several species (adapted from Csapo et al., 2009, Dimitrov et al., 2007, Haenlein and Anke, 2011; 
Park and Haenlein, 2006; Michaelidou, 2008; Belewu et al., 2009). 
MINERALS AND TRACE 
ELEMENTS 
(mg Kg-1) 
Cow Human Goat Sheep Buffalo Mare Camel 
Calcium (Ca) 1190-1220 330 1340-1500 1930 1830 485-1355 760–1965 
Phosphorus (P) 930-1190 430 960-1210 1580 820 216-1205 490–1480 
Potassium (K) 1520-1520 550 1700-1810 1360 1070 303-790 600–2110 
Sodium (Na) 490-580 150 410 440 440 75-237 360–902 
Magnesium (Mg) 120-130 40 93-160 180 180 29-118 40–209 
Chlorine (Cl) 1000-1030 600 1500  580   
Sulfur (S) 320  29  157-314    
        
Zinc (Zn) 3.8-5.3 3.8 2.7-5.6 5.7 3.2-7.3  2.2-3.6 2.8-4.4 
Iron (Fe) 0.5-0.8 2.0 0.7-4.0 0.8 0.4-13  0.5-1.1 0.-3.7 
Copper (Cu) 0.2-0.6 0.6 0.5-1.0 0.4 0.07-2.6  0.2-0.7 0.11-1.5 
Manganese (Mn) 0.2-0.3 0.7 0.3-1.0 0.07 0.38-0.66 0.05 0.2-1.9 
        
Aluminum (Al) 0.6  1.12 0.5-1.8    
Cadmium (Cd) 0.004  0.005 0.03-0.06    
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Cobalt (Co) 0.0008   0.004-0.09 0.7-1.6   
Chromium (Cr) 0.02   0.04-0.4    
Nickel (Ni) 0.02  0.288 0.01-0.4    
Barium (Ba) 0.2   1.7    
Lead (Pb) 0.03   0.006    
Selenium (Se) 0.0096-0.02 0.0152 0.013-0.247     
Fluorine (F) 0.1    0.4-18.5   
Iodine (I) 0.08/0.21 0.07 0.22  8.6-19.4   
Molybdenum (Mo) 0.06  0.116     
VITAMINS 
(mg Kg-1) 
       
Retinol, vit. A 0.38-0.52 0.57 0.55 0.84 0.102 0.34  
Thiamin, vit. B1 0.28-0.90 0.14-0.17 0.68 0.8 0.5  0.33-0.6 
Riboflavin, vit. B2 1.2-2.0 0.2-0.36 2.1 3.56 1.0  0.42-0.8 
Pyridoxin, vit. B6 0.42-0.63 0.11 0.46 0.8 3.8  0.52 
Cobalamin, vit. B12 0.002-0.007 0.0003-0.0005 0.0007 0.007 3.4  0.002 
Vitamin D  0.0003-0.0005 0.0004 0.0006 0.0018  0.0032  
Tocopherol, vit. E 0.31-0.9   1.1 0.334 1.128  
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Ascorbic acid 3-23 35-50 12.9 41.6 23-30 17.2 24-52 
Folic acid 0.01-0.1 0.055 0.01 0.05 0.1  0.004 
Niacin 0.5-0.84 1.47-1.7 2.7 4.16   4-6 
Pantothenic acid 2.6-4.9 1.84-2.23 3.1 4.08 1.5  0.88 
Biotin 0.02 0.004 0.015  26.8   
IMMUNE COMPONENTS        
Immunoglobulins (%) 10.1-11.7 15.1-19.7    18.7-20.9  
IgA (milk: g ml-1) 140 1000 30-80     
IgA (colostrum: mg ml-1) 3.9 17.35 0.9-2.4     
IgM (milk: g ml-1) 50 100 10-40     
IgM (colostrum: mg ml-1) 4.2 1.59 1.6-5.2     
IgG (milk: g ml-1) 590 40 100-400 350-500 450-600  1700 
IgG (colostrum: mg ml-1) 47.6 0.43 50-60     
Lactoferrin (g ml-1) 20-200  2000 20-200 20-200 20-200 20-200 150-250 
POLYAMINES 
(mol L-1) 
       
Putrescine 1 0.4 5.12-6 0.4    
Spermidine 1-4.7 2.7 26-39.67 2.05    
52 
 
Spermine 1-4 1 3.18-3.8 2.39    
NUCLEOSIDES 
(mol L-1) 
       
Cytosine 2.4-5.8 4.3-7.8 8.8 6.7    
Uridine 14.7-73.1 0.5-6.9 17.9-76.3 67.8    
Inosine 1-6.5  12.8-60.6 41.2    
Guanosine 0.8 0.2-1 2.3-2.9 2.1    
Adenosine 1.4 3-5.3 2.4-3.4 8.8    
NUCLEOTIDES 
(mol L-1) 
       
Cytidyl-5’-monophosphate 2.9-26.6 18.3-66 72.5 48.6    
Uridyl-5’-monophosphate Traces 6.4-9.3 227.2 110.7    
Guanosyl-5’-
monophosphate 1.8 1-1.5 Traces Traces    
Adenosyl-5’-
monophosphate Traces 1.9-15.1 85.6 54.1    
ESSENTIAL AMINO 
ACIDS Cow Human Goat Sheep Buffalo Mare Camel 
Alanine (g Kg-1) 1.08 3.42 0.89 2.17  0.59  
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Arginine (g Kg-1) 1.15-1.98  3.09 0.75 1.2-1.84  0.95 3.92 
Cysteine (g Kg-1) 0.31 1.73 0.23 0.44 0.59 0.18  
Glycine (g Kg-1) 0.61 1.89 0.47 0.98  0.25  
Histidine (g Kg-1) 1.68-8.10 1.97-2.17 0.67-2.23 0.88-1.41  0.35 1.95-2.15 
Isoleucine (g Kg-1) 1.58-3.38 2.33-4.53 1.24-2.15 2-2.66 5.71 0.62 2.94-5.71 
Leucine (g Kg-1) 3.33-5.88 2.71-8.85 2.48-2.68 3.22-4.89 9.79 1.47 2.71-8.55 
Lysine (g Kg-1) 2.90-5.12 5.36-6.09 2.06-5.48 2.6-4.51 7.50 1.16 3.75-4.26 
Methionine (g Kg-1) 0.88-1.56 1.36-1.46 1.43 0.84-1.57 0.93 0.35 2.42-2.60 
Phenylalanine (g Kg-1) 1.68-2.84 2.58-3.15 1.21-1.99 1.6-2.6 4.71 0.68 3.15-3.84 
Threonine (g Kg-1) 1.41-2.68 3.56- 3.75 1.26-3.31 1.48-2.22 3.57 0.62 2.39-2.51 
Tryptophan (g Kg-1) 0.84 5.22 5.11 0.46   12.53 
Tyrosine (g Kg-1) 1.58 3.93 0.98 2.55 3.86 0.72  
Valine (g Kg-1) 1.75-4.48 4.35 1.57 2.2-3.10 6.74 0.75 3.39 
        
Branched-chain amino 
acids (g Kg-1) 
7.02- 13.64 1.78 5.29 7.44-10.77  2.81  
        




Table 2. Concentrations and activities of some indigenous enzymes in milk from several species (adapted from Chen et al., 2003; Seifu et al., 2005; Fox and 
Kelly, 2006a; Park and Haenlein, 2006).  
ENZYME  
concentration and/or activity 
Cow Human Goat Sheep Buffalo Camel 
Acid phosphatase (AcP) 0.75 U ml-1  1.4 U ml-1    
Alkaline phosphatase (AIP) 1.8 -2.5 U ml-1   
11-13 mg L-1 
 1.2-1.7 U ml-1  
Amylase     1.2-1.7 U ml-1  
Lactoperoxidase (LPO) 30 mg L-1 
1.5 - 2.7 U ml-1 
1.5 mg L-1 
0.06 -0.97 U ml-1 
 
1.55-4.45 U ml-1 
 
0.77- 3.46 U ml-1 
0.2-0.9 U ml-1 1.5 U ml-1 
Lipoprotein lipase (LPL) 0.5-2.0 mg ml-1 4-20 mg ml-1     
Lysozyme  10-35 g 100 ml-1 4-40 g 100 ml-1 25 g 100 ml-1 23-50 g 100 ml-1 13-15.2 g 100 ml-1 228-500 g 100 ml-1 
Plasmin  0.07– 0.3 g ml-1 0.07– 0.13 g ml-1     
Ribonuclease (RNase)  1000-2000 g 100 ml-1 10-20 g 100 ml-1 425 g 100 ml-1    
Sulphydryl oxidase (SHOx)  33 mg ml-1      
Xanthine oxidoreductase (XOR)  120 (l O2 h-1 ml-1) 12(l O2 h-1 ml-1) 
 






Table 3. Indigenous bovine milk enzymes (adapted from Kelly and McSweeney, 2003; Fox and Kelly, 2006a; Huppertz and Kelly, 2009). 
Enzyme EC 
number 










micelle in milk 
Serine protease 
Active on all 
caseins, particularly 
on -casein and 
s2-casein 
7.5 37 Most plasmin survives 
pasteurization, though 
considerable inactivation 
occurs at higher temperatures 
Thermal inactivation depends 
also on the presence of -
lactoglobulin 
Cheesemaking properties of milk 
deteriorate as a result of plasmin 
activity 
In the cheese itself, plasmin 
contributes to primary proteolysis 
Plasmin and plasminogen have a 
role in the physical instability or age 










some in the 
serum phase 
Glycoprotein 
Liberates fatty acids 
from the 1 and 3 
position in tri-, di- 
and 
monoglycerides 
9.2 37 Heat-labile enzyme 
Very little activity survives 
pasteurization 
Complete thermal inactivation 
occurs for heat treatment 
exceeding 75ºC for 15 min 
Technologically significant enzyme 
from the viewpoint of milk 
deterioration 
Lipolysis leads to the release of free 
fatty acids, which can result in the 
development of hydrolytic rancidity 
Alkaline 
phosphatase 






the milk fat 
Phosphomonoester
ase 
Active against a 
wide range of 
substrates 
Hydrolyses most 
9.0-10.5 37 Relatively heat-sensitive 
Its thermal stability is only 
slightly higher than that of 
non-spore forming 
pathogenic bacteria present 
in milk 
Its thermal inactivation has been 
effectively used as a sensitive 
indicator for adequate 
pasteurization of milk 
However, this enzyme can be 
reactivated on subsequent storage, 


























8.0 - Possesses antibacterial 
activity in the presence of 
H2O2 and thiocyanate through 
the catalysis of the oxidation 
of thiocyanate to 
hypothiocyanate 
Heat-stable enzyme.  
Thermal inactivation for 
temperatures up to 80ºC  
Preservation of milk quality 
Indices of the thermal history of milk 
Antimicrobial activity 








Table 4.  Significance of indigenous bovine milk enzymes for the production and/or quality of 
milk and milk products (adapted from Kelly and Fox, 2006a,b) 
Product Enzyme Significance 




Pasteurized milk Plasmin 
Alkaline phosphatase 
Possible contribution to instability 
Index of processing 
UHT milk Plasmin Possible contribution to gelation on storage 
Cream Lipase 
Lactoperoxidase 
Can cause rancidity 
Indicator of heat treatment 
Milk powders Lipase 
Plasmin 
Can cause rancidity 
Can survive drying and remain active 
Yogurt Lactoperoxidase 
Plasmin 
Possible inhibition of post-acidification 
Possible effect on gel structure and texture 
Fresh cheese Plasmin Affects rennet coagulation in milk 













Contributes to primary proteolysis 
Contributes to lipolysis 
 
May contribute to proteolysis due to inactivation of 
chymosin 













Table 5. Bovine milk hormones (adapted from Jouan et al., 2006)  
Hormone Concentration range (ng mL-1) 
Estrogen 5 x 10-3 -10 x 10-3 
Progesterone  2-20  
Glucocorticoids 0-50  
Prolactin 5-200  
Growth hormone 0-1  
Somatostatin  10-30 




Melatonin 5 x 10-3-25 x 10-3 
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Source Primary activity Amino acid 
residues 
Molecular 
mass (g mol-1) 
pI 
EGF  2.0 Wide range of 
tissues and body 
fluids 
Stimulates proliferation of epidermal, epithelial and embryonic cells 
Inhibits secretion of gastric acid 
Promotes wound healing and bone resorption 
53 6000 4.8 
BTC 1.9 80 22 000 7.7 
IGF-I 30.4 Primarily the liver Stimulates proliferation of many cell types 
IGF-I is a stronger mitogen than IGF-II  which stimulates primarily 
cells of fetal origin 
Influences the differentiation of some cells 
Causes hypoglycemia, improvement of nitrogen balance, lowering of 
cholesterol and potassium, and improvement of renal functions    
70 7650 7.8 
IGF-II 50-100 Variety of cells 67 7530 6.5 
TGF-2 13-71 Platelets and many 
other cells 
Stimulates growth of cells, especially in connective tissue 
Inhibits other cells, such as lymphocytes and epithelial cells 
Important role in embryogenesis, wound healing, formation of bone 
and cartilage, and control of the immune system 
425 25 000 7.7 
PDGF NA Platelets and many 
other cells 
Plays a role in embryonic development, proliferation of cells of 
mesenchymal origin, migration, angiogenesis and wound healing 
250-300 30 000 9.6 
FGF2 0.5-1 Wide range of cells Important role in proliferation, differentiation and survival of many cell 
types 
Involved in angiogenesis, wound healing and hematopoiesis 
146 16 400 9.6 
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EGF – estrogen growth factor; BTC – betacellulin; IGF – insulin growth factor; TGF - transforming growth factor; PDGF - platelet-derived growth factor; FGF - fibroblast growth 
factor;  NA – not available 
 
 
